11-47410177-A-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001128225.3(SLC39A13):āc.83A>Gā(p.Glu28Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.991 in 1,613,612 control chromosomes in the GnomAD database, including 793,255 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_001128225.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC39A13 | NM_001128225.3 | c.83A>G | p.Glu28Gly | missense_variant | 2/10 | ENST00000362021.9 | NP_001121697.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC39A13 | ENST00000362021.9 | c.83A>G | p.Glu28Gly | missense_variant | 2/10 | 1 | NM_001128225.3 | ENSP00000354689.4 |
Frequencies
GnomAD3 genomes AF: 0.952 AC: 144885AN: 152132Hom.: 69384 Cov.: 33
GnomAD3 exomes AF: 0.988 AC: 246022AN: 248998Hom.: 121755 AF XY: 0.991 AC XY: 134020AN XY: 135208
GnomAD4 exome AF: 0.995 AC: 1453945AN: 1461362Hom.: 723854 Cov.: 74 AF XY: 0.996 AC XY: 723849AN XY: 726988
GnomAD4 genome AF: 0.952 AC: 144954AN: 152250Hom.: 69401 Cov.: 33 AF XY: 0.954 AC XY: 71022AN XY: 74432
ClinVar
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 25, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, Amsterdam University Medical Center | - | - - |
Ehlers-Danlos syndrome, spondylocheirodysplastic type Benign:3
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at